Controversial US-backed vaccine trial in African newborns halted
U.S. health officials have stopped a hepatitis B vaccine trial planned for newborns in Guinea-Bissau after widespread criticism. The study, which would have been financed by the Centers for Disease Control and Prevention, faced concerns over ethics and safety. Researchers announced the project will not proceed, citing the intense global backlash and the study will not proceed further.